Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
GLOBETECH PUBLISHING LLC
Ampronix

MR-Guided Ultrasound Offers Effective Noninvasive Treatment for Breast Cancer

By Medimaging International staff writers
Posted on 16 Dec 2013
Image: PRE: Pretreatment transverse MR image obtained with perfusion technique shows an enhancing lesion of 1.2 cm (circled) in the upper quadrants of the right breast; the lesion shows with irregular margin and appears color-coded in red due to the washout pattern (malignancy). POST: Same MR image technique obtained post-treatment (10 days): Absence of enhancement was seen at perfusion color-coded image after noninvasive thermal ablation with MR-guided high-intensity focused ultrasound; the black hole stands for necrosis nicely demonstrating also the absence of residual tumor (Photo courtesy of RSNA).
Image: PRE: Pretreatment transverse MR image obtained with perfusion technique shows an enhancing lesion of 1.2 cm (circled) in the upper quadrants of the right breast; the lesion shows with irregular margin and appears color-coded in red due to the washout pattern (malignancy). POST: Same MR image technique obtained post-treatment (10 days): Absence of enhancement was seen at perfusion color-coded image after noninvasive thermal ablation with MR-guided high-intensity focused ultrasound; the black hole stands for necrosis nicely demonstrating also the absence of residual tumor (Photo courtesy of RSNA).
A technique that utilizes focused ultrasound under magnetic resonance imaging (MRI) guidance to heat and destroy tumors may offer a safe and effective treatment for breast cancer.

The new findings were presented according to research being presented today at the annual meeting of the Radiological Society of North America (RSNA), held in December 1-6, 2013, in Chicago (IL, USA). MR-guided focused ultrasound (MRgFUS) ablation is a noninvasive technique that requires no incision or puncture to perform. Instead, it uses the acoustic energy from high-intensity focused ultrasound to ablate diseased tissue. Continuous MRI scanning is employed to locate the lesions and monitor the temperature change during the ablation process.

The primary advantages of MRgFUS over other breast cancer treatments are that it is a noninvasive, outpatient procedure offering a quick recovery time, and that it provides precise measurement of temperature alterations during the procedure. “In the treatment stage, we are able to precisely visualize where the energy is having an effect and to measure exactly the rise in temperature,” said Alessandro Napoli, MD, PhD, assistant professor of radiology at Sapienza University (Rome, Italy). “Temperature monitoring is particularly important since too low a temperature is ineffective and too high a temperature may be dangerous.”

Dr. Napoli and colleagues evaluated the safety and efficacy of MRgFUS in 12 patients with invasive ductal breast cancer before surgical removal of the cancer and biopsy of the lymph nodes. They used 3T MRI to validate the presence and treatable location of cancerous lesions. The patients then underwent single-session MRgFUS treatment. Researchers evaluated treatment efficacy through postsurgery pathology.

None of the patients experienced significant complications during or immediately after the procedure. In 10 of the 12 patients, MRI scans revealed no enhancement in the treatment area after the procedure. Postsurgery histological evaluation confirmed the absence of residual disease in the treatment area in those 10 patients. “This procedure allows for safe ablation of breast cancer,” Dr. Napoli said. “At pathology, no significant viable tumor was found in the specimens from these 10 patients.”

In the other two instances, treatment failed due to transducer malfunction, and the pathologist observed residual tumor in the samples.

According to Dr. Napoli, MRI guidance is crucial for correct identification of lesions, treatment planning and real-time control during the procedure. Specifically, tracking with MRI allows for efficient deposit of energy into the region of treatment at the correct range of between 60 °C and 70 °C. “This is carried out by a special sequence that is called MR thermometry,” Dr. Napoli said. “Only MRI presently has the ability to determine, in real time, fine temperature quantification.”

Even though these preliminary findings are promising, Dr. Napoli noted that more studies would be needed before the approach can be adopted as a stand-alone treatment for breast cancer.

Related Links:

Sapienza University



Channels

Radiography

view channel
Image: Carestream DRX-Excel Plus Fluoroscopy Imaging System (photo courtesy of Carestream).

Carestream Enters Radiography/Fluoroscopy Sector with Two Systems

Carestream has entered the radiography/fluoroscopy market with two new imaging systems and an optional flat panel detector that can also be used for general radiography. The systems can be used to perform... Read more

Nuclear medicine

view channel

New Imaging Collaboration Could Improve Treatment and Quality of Life of Prostate Cancer Patients

A development agreement between a large medical imaging vendor and smaller medical device company promises to help promote a unique minimally invasive treatment that can ablate the prostate gland. The agreement will give the device developer access to a large installed base of Magnetic Resonance Imaging (MRI) systems,... Read more

General/Advanced Imaging

view channel
Image: Illustration of a new technique using Optical Coherence Tomography that could help surgeons differentiate a human brain tumor, red, from surrounding noncancerous tissue, green (Photo courtesy of  Carmen Kut, Jordina Rincon-Torroella, Xingde Li and Alfredo Quinones-Hinojosa/Johns Hopkins Medicine).

Imaging Technique Helps Safer and More Effective Removal of Brain Tumors

Researchers at the Johns Hopkins University have demonstrated a new imaging technology that could enable neurosurgeons to better differentiate between healthy and cancerous brain tissue and perform safer... Read more

Imaging IT

view channel
Image: The Arbor Solution M2150 medical workstation with 21.5\

Multifunction Workstation Screen Meets Critical Certification Standards for Medical Environments

A medical imaging equipment vendor has unveiled a new workstation with a 54.61 cm true flat screen designed for operating rooms, clinical stations, and Picture Archiving and Communications Systems (PACS).... Read more

Industry News

view channel

Guerbet Aims for Global Medical Imaging Leadership by Acquisition of Mallinckrodt’s CMDS Business

Guerbet (Paris, France) has announced a definitive agreement for the acquisition of the Contrast Media and Delivery Systems (CMDS) business of pharmaceutical giant Mallinckrodt (Chesterfield, Derbyshire, UK). The acquisition gave Guerbet and the CMDS unit combined pro-forma sales of nearly EUR 800 million in 2014, a... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.